CN111567708A - 山药黄精复合饮品制备方法 - Google Patents
山药黄精复合饮品制备方法 Download PDFInfo
- Publication number
- CN111567708A CN111567708A CN202010278504.5A CN202010278504A CN111567708A CN 111567708 A CN111567708 A CN 111567708A CN 202010278504 A CN202010278504 A CN 202010278504A CN 111567708 A CN111567708 A CN 111567708A
- Authority
- CN
- China
- Prior art keywords
- preparation
- rhizoma polygonati
- chinese yam
- extract
- compound beverage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 35
- 150000001875 compounds Chemical class 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims abstract description 33
- 235000002722 Dioscorea batatas Nutrition 0.000 title claims abstract description 30
- 235000006536 Dioscorea esculenta Nutrition 0.000 title claims abstract description 30
- 240000001811 Dioscorea oppositifolia Species 0.000 title claims abstract description 30
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 title claims abstract description 30
- 239000000284 extract Substances 0.000 claims abstract description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229940098465 tincture Drugs 0.000 claims abstract description 18
- 238000001914 filtration Methods 0.000 claims abstract description 17
- 239000000203 mixture Substances 0.000 claims abstract description 13
- 241000251468 Actinopterygii Species 0.000 claims abstract description 11
- 238000010438 heat treatment Methods 0.000 claims abstract description 10
- 238000003756 stirring Methods 0.000 claims abstract description 10
- 239000012153 distilled water Substances 0.000 claims abstract description 9
- 108010011485 Aspartame Proteins 0.000 claims abstract description 8
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims abstract description 8
- 229960003438 aspartame Drugs 0.000 claims abstract description 8
- 235000010357 aspartame Nutrition 0.000 claims abstract description 8
- 239000000605 aspartame Substances 0.000 claims abstract description 8
- 238000009835 boiling Methods 0.000 claims abstract description 8
- 239000000706 filtrate Substances 0.000 claims abstract description 8
- 238000002791 soaking Methods 0.000 claims abstract description 8
- 238000004140 cleaning Methods 0.000 claims abstract description 5
- 235000008422 Schisandra chinensis Nutrition 0.000 claims description 14
- 240000006079 Schisandra chinensis Species 0.000 claims description 11
- 241000270708 Testudinidae Species 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 8
- 235000004879 dioscorea Nutrition 0.000 claims description 8
- 230000001954 sterilising effect Effects 0.000 claims description 8
- 241000270666 Testudines Species 0.000 claims description 7
- 210000000988 bone and bone Anatomy 0.000 claims description 6
- 210000001835 viscera Anatomy 0.000 claims description 6
- 238000005360 mashing Methods 0.000 claims description 5
- 241000252233 Cyprinus carpio Species 0.000 claims description 4
- 241000252232 Hypophthalmichthys Species 0.000 claims description 4
- 238000002386 leaching Methods 0.000 claims description 4
- 239000008213 purified water Substances 0.000 claims description 4
- 239000011780 sodium chloride Substances 0.000 claims description 4
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 4
- 239000001509 sodium citrate Substances 0.000 claims description 4
- 241000950619 Geothlypis Species 0.000 claims description 3
- 241000736075 Schisandra Species 0.000 claims description 3
- 241001673303 Terrapene Species 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 210000003491 skin Anatomy 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 230000003712 anti-aging effect Effects 0.000 abstract description 6
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 230000036541 health Effects 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 9
- 239000000047 product Substances 0.000 description 7
- 206010003549 asthenia Diseases 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 230000032683 aging Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
- 235000003704 aspartic acid Nutrition 0.000 description 3
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 201000002364 leukopenia Diseases 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000001243 protein synthesis Methods 0.000 description 3
- 206010043554 thrombocytopenia Diseases 0.000 description 3
- 229940126680 traditional chinese medicines Drugs 0.000 description 3
- 230000014616 translation Effects 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 208000037259 Amyloid Plaque Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 241000252231 Cyprinus Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000252234 Hypophthalmichthys nobilis Species 0.000 description 2
- 241000255588 Tephritidae Species 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 238000009098 adjuvant therapy Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 208000033065 inborn errors of immunity Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 231100001022 leukopenia Toxicity 0.000 description 2
- -1 lipid peroxide Chemical class 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000009707 neogenesis Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000011824 nuclear material Substances 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000009758 senescence Effects 0.000 description 2
- 230000036299 sexual function Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 208000032467 Aplastic anaemia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000007117 Oral Ulcer Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000002431 foraging effect Effects 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 210000004524 haematopoietic cell Anatomy 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000013095 identification testing Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Nutrition Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Reproductive Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Marine Sciences & Fisheries (AREA)
- Emergency Medicine (AREA)
Abstract
本发明公开了一种山药黄精复合饮品制备方法，其步骤为：将10‑15g五味子用清水清洗沥干，加入浓度为90％‑95％的食用乙醇10‑30ml，浸泡30‑40天，经多层纱过滤得五味子酊备用；在15‑30g山药中加浓度为90％‑95％的食用乙醇20‑60ml，浸泡30‑40天后过滤，得山药酊备用；用冷水清洗55‑60g生黄精，加蒸馏水90‑l10ml，煮沸20‑40分钟，趁热过滤，得滤液；将制得的生黄精滤液倒入配制罐中，边加热边倒入80‑120ml鱼提取物，并不断搅拌，煮沸20‑40分钟，再低温煎煮10‑15分钟；向配制罐中加入五味子酊、山药酊，再加入80‑120g龟提取物后停止加热，并趁热将配制罐中的混合物过滤，加入蛋白糖搅拌溶解；加蒸馏水至800‑1200ml，冷却至室温后灌装、灭菌，即得。本发明具有明显的抗衰老保健作用、能辅助治疗多种疾病，且其加工制作简单，易操作。
Description
技术领域
本发明涉及一种保健品技术领域，具体说涉及一种山药黄精复合饮品制备方法。
背景技术
目前国内抗衰老药品大都以中药为主要成分，其成分复杂，加工方法原始，难以把有害物质与有益物质区分开来，在治疗上缺乏科学理论依据。也有些抗衰老产品以维生素、微量元素和激素等类物质作为基本成份，一般只能起到维持正常生理代谢的作用，不能真正的延缓衰老。
衰老是机体组织再生性细胞分化大于分裂，致使老化细胞大于细胞的新生而引起的，而造成这一现象的原因是其蛋白质的合成速率超过细胞核中的核物质(DNA)的合成的速率所致。而通过调节组织再生性细胞的核物质(主指DNA)与蛋白质合成的相对速率可以控制衰老的进程。
因此，如何设计一种可真正延缓衰老的保健品是本发明人潜心研究的课题。
发明内容
本发明的目的是提供一种山药黄精复合饮品制备方法，其具有明显的抗衰老保健作用、能辅助治疗多种疾病，且其加工制作简单，易操作。
为了实现上述方案，本发明的技术解决方案为：一种山药黄精复合饮品制备方法，所述复合饮品按重量份包括以下成分：五味子10-15g、山药15-30g、生黄精55-60g、龟提取物80-120g、鱼提取物80-120ml，其制作步骤为；
(1)将所述五味子用清水清洗沥干，加入浓度为90％-95％的食用乙醇10-30ml，浸泡30-40天，经多层纱过滤得五味子酊备用；
(2)在所述山药加浓度为90％-95％的食用乙醇20-60ml，浸泡30-40天后过滤，得山药酊备用；
(3)用冷水清洗所述生黄精，加蒸馏水90-l10ml，煮沸20-40分钟，趁热过滤，得滤液；
(4)将步骤(3)中制得的生黄精滤液倒入配制罐中，边加热边倒入所述鱼提取物，并不断搅拌，煮沸20-40分钟，再低温煎煮10-15分钟；
(5)向所述配制罐中加入步骤(1)制得的五味子酊、步骤(2)制得的山药酊，再加入所述龟提取物后停止加热，并趁热将配制罐中的混合物过滤，并加入蛋白糖搅拌溶解；
(6)加蒸馏水至800-1200ml，冷却至室温后灌装、灭菌，即得。
本发明山药黄精复合饮品制备方法，其中所述龟提取物是通过以下步骤提取：
(1)将新鲜的乌龟、黄喉水龟或黄缘闭壳龟去掉壳、板、骨、内脏后的新鲜体，按照每500克新鲜体加入1000ml的提取液，捣碎成破碎液；
(2)在破碎液中加入2000ml提取液，浸提25-35分钟，再静置25-35分钟，得到3000ml匀浆液。
本发明山药黄精复合饮品制备方法，其中所述鱼提取物是通过以下步骤提取：
(1)将新鲜的鲤科动物鳙或鲤科动物鲢去头、尾、皮、骨、内脏后得到的新鲜体，按照每500克新鲜体加入1000ml的提取液，捣碎成破碎液；
(2)在破碎液中加入2000ml提取液，浸提25-35分钟，再静置25-35分钟，得到3000ml匀浆液。
本发明山药黄精复合饮品制备方法，其中所述提取液是由枸檬酸钠、氯化钠与纯化水按质量比为2-3：1：150-200配制而成。
本发明山药黄精复合饮品制备方法，其中所述步骤(5)的混合物趁热通过板框过滤器进行过滤。
本发明山药黄精复合饮品制备方法，其中所述步骤(6)采用灭菌柜(110℃-130℃，1-2磅)灭菌5-10分钟即得。
采用上述方案后，本发明山药黄精复合饮品制备方法通过上述制备步骤，其制作方便简单，制出的复合饮品具有改善体质、提高生命效力，调整机体功能失调，延缓衰老，增强记忆力的作用。适用于年老体质衰弱及由于多种原因包括手术后及心脑血管疾病、糖尿病等代谢性疾病，放射治疗等引起的免疫功能低下，体质衰弱以及血小板、白细胞减少的辅助治疗。对消退老年斑、蝴蝶斑，修复口腔慢性溃疡，提高性功能的疗效比较明显。可使老年人的多项生理指标向年轻状态转化；服用该复合饮品的人的血浆脂质过氧化物比未服用的人降低5-7倍，中性粒细胞吞噬指数是未服用人的3-4倍，淋巴细胞转化刺激指数是未服用人的3-4倍，对老年性疾病的总疗效率高。
本发明山药黄精复合饮品的用量为：每人每天服用(10ml/支)。
具体实施方式
现举一实施例对本发明山药黄精复合饮品制备方法进行详细说明。
本发明山药黄精复合饮品制备方法，包括如下步骤：
(1)称取五味子10g，用清水清洗沥干，加浓度为95％的食用乙醇20ml浸泡1个月，经多层纱过滤得五味子酊备用；
(2)称取山药20g加浓度为95％的食用乙醇40ml，浸泡1个月后过滤，得山药酊备用；
(3)称取生黄精60g，用冷水清洗，加蒸馏水l00ml，煮沸30分钟，趁热过滤，得滤液；
(4)将步骤(3)中制得的生黄精滤液倒入配制罐中，边加热边倒入100ml鱼提取物，开动搅拌浆并不断搅拌，煮沸30分钟，再低温煎煮10-15分钟；
再加入五味子酊、山药酊、最后加入龟提取物，随即关闭加热阀，趁热板框过滤器过滤，并加入蛋白糖，搅拌溶解，加蒸馏水至l000ml，冷却后灌装，用灭菌柜(120℃，1.5磅)灭菌5分钟，即得。(鱼和龟提取物的制法见上面)。
(5)向所述配制罐中加入步骤(1)制得的五味子酊、步骤(2)制得的山药酊，再加入龟提取物100g后，随即关闭加热阀停止加热，并趁热将配制罐中的混合物通过板框过滤器进行过滤，并加入蛋白糖搅拌溶解；
(6)加蒸馏水至1000ml，冷却至室温后灌装，采用灭菌柜(120℃，1.5磅)灭菌5分钟，即得本复合饮品，该复合饮品的蛋白质大于等于2.00％。
其中上述龟提取物是通过以下步骤提取：
(1)将新鲜的乌龟、黄喉水龟或黄缘闭壳龟去掉壳、板、骨、内脏后的新鲜体，按照每500克新鲜体加入1000ml的提取液，捣碎成破碎液，提取液是由588g枸檬酸钠、236g氯化钠与40000ml纯化水配制而成；
(2)在破碎液中加入2000ml提取液，浸提30分钟，再静置30分钟，得到约15％的匀浆液3000ml。
鱼提取物是通过以下步骤提取：
(1)将新鲜的鲤科动物鳙或鲤科动物鲢去头、尾、皮、骨、内脏后得到的新鲜体，按照每500克新鲜体加入1000ml的提取液，捣碎成破碎液，提取液是由588g枸檬酸钠、236g氯化钠与40000ml纯化水配制而成；
(2)在破碎液中加入2000ml提取液，浸提30分钟，再静置30分钟，得到约15％的匀浆液3000ml。
本发明复合饮品经动物实验表明：能使小鼠的SOD酶抑制提高41.5％，抗缺氧能力提高到65％，使耐高温(50℃)时间提高3.5倍以上，单核白血细胞升高2.87倍。用1％浓度的长生露喂养果蝇，可使果蝇的平均寿命提高68.7％。
应用实例：
经82例使用者实验表明：本发明复合饮品具有改善体质、提高生命效力，调整机体功能失调，延缓衰老，增强记忆力的作用。适用于年老体质衰弱及由于多种原因包括手术后及心脑血管疾病、糖尿病等代谢性疾病，放射治疗等引起的免疫功能低下，体质衰弱以及血小板、白细胞减少的辅助治疗。对消退老年斑、蝴蝶斑，修复口腔慢性溃疡，提高性功能的疗效比较明显。可使老年人的多项生理指标向年轻状态转化。
通过临床疗效鉴定测试。采用对照单盲法，随机分配病例，共作了200例。每人每天服1支“长生露”牌山药黄精复合饮品(10ml/支)，连服3个月，经过体测与血相检测发现，服“长生露”牌山药黄精复合饮品组血浆脂质过氧化物降低率是未服用组的5.6倍，中性粒细胞吞噬指数是未服用组的3.5倍，淋巴细胞转化刺激指数是未服用组的3.6倍，对十种被检测的老年性疾病的总疗效率达83.7％。
本发明复合饮品中的龟提取物(活性多肽)主要起调节蛋白质合成与核物质合成的相对速率的作用，鱼提取物(DNA)要起补充核物质合成原料(脱氧核苷酸)的作用；将它们组合在一起时有促进再生性细胞分裂，降低其细胞的分化衰老速度的作用，因此可促进组织细胞的新生，造血细胞与原生殖细胞的增殖，升高白血细胞与血小板、血细胞指数，并有调节升高组织细胞代谢活性，软化血管，促进SOD酶的合成等作用。在临床上可望成为抗辐射副反应、口腔溃疡、再生性障碍贫血及血小板减少、白细胞低下，性功能低下的预防和治疗药物。同时亦可成为衰老、病后体虚的强壮药物及正常人的保健药物。
本复合饮品中加入的五味子是基于五味子本身是中药中被历史公认的抗衰老药物，其醇提取物经实验证明有促进细胞分裂的作用，并有延长实验动物寿命的作用。有文献研究表明：五味素还有抑制转氨酶活性的作用，这对合成核苷酸的原料，天门冬氨与谷氨酰胺的降解有保护作用；通常天门冬氨酸在组织细胞中的降解很快，因此天门冬氨酸在血液中浓度很低。
本复合饮品中加入山药是基于山药中有补肾、抗衰老作用，其醇提取物有抑制嘌呤代谢系统的分解代谢的作用(参见《抗衰老中药有效成分研究》)，并且其醇提取物还有除血腥味的作用。
本品中加入黄精主要作为调味剂；《本草便谈》中有“黄精为滋腻之品……此品味甘如饴，情平质润，为补养脾阴之正品”之说。
蛋白糖是调味剂。蛋白糖不仅甜味高、纯正，而且久放不与其它有效成分起反应，利于药品存放。同时组成蛋白糖的成分天门冬氨酸与苯丙氨酸可为本品的营养补充剂。
以上所述实施例仅仅是对本发明的优选实施方式进行描述，并非对本发明的范围进行限定，在不脱离本发明设计精神的前提下，本领域普通工程技术人员对本发明的技术方案作出的各种变形和改进，均应落入本发明的权利要求书确定的保护范围内。
Claims (6)
1.一种山药黄精复合饮品制备方法，所述复合饮品按重量份包括以下成分：五味子10-15g、山药15-30g、生黄精55-60g、龟提取物80-120g、鱼提取物80-120ml，其特征在于制作步骤为；
(1)将所述五味子用清水清洗沥干，加入浓度为90％-95％的食用乙醇10-30ml，浸泡30-40天，经多层纱过滤得五味子酊备用；
(2)在所述山药加浓度为90％-95％的食用乙醇20-60ml，浸泡30-40天后过滤，得山药酊备用；
(3)用冷水清洗所述生黄精，加蒸馏水90-l10ml，煮沸20-40分钟，趁热过滤，得滤液；
(4)将步骤(3)中制得的生黄精滤液倒入配制罐中，边加热边倒入所述鱼提取物，并不断搅拌，煮沸20-40分钟，再低温煎煮10-15分钟；
(5)向所述配制罐中加入步骤(1)制得的五味子酊、步骤(2)制得的山药酊，再加入所述龟提取物后停止加热，并趁热将配制罐中的混合物过滤，并加入蛋白糖搅拌溶解；
(6)加蒸馏水至800-1200ml，冷却至室温后灌装、灭菌，即得。
2.根据权利要求1所述的山药黄精复合饮品制备方法，其特征在于，所述龟提取物是通过以下步骤提取：
(1)将新鲜的乌龟、黄喉水龟或黄缘闭壳龟去掉壳、板、骨、内脏后的新鲜体，按照每500克新鲜体加入1000ml的提取液，捣碎成破碎液；
(2)在破碎液中加入2000ml提取液，浸提25-35分钟，再静置25-35分钟，得到3000ml匀浆液。
3.根据权利要求1所述的山药黄精复合饮品制备方法，其特征在于，所述鱼提取物是通过以下步骤提取：
(1)将新鲜的鲤科动物鳙或鲤科动物鲢去头、尾、皮、骨、内脏后得到的新鲜体，按照每500克新鲜体加入1000ml的提取液，捣碎成破碎液；
(2)在破碎液中加入2000ml提取液，浸提25-35分钟，再静置25-35分钟，得到3000ml匀浆液。
4.根据权利要求2或3所述的山药黄精复合饮品制备方法，其特征在于，所述提取液是由枸檬酸钠、氯化钠与纯化水按质量比为2-3：1：150-200配制而成。
5.根据权利要求1所述的山药黄精复合饮品制备方法，其特征在于，所述步骤(5)的混合物趁热通过板框过滤器进行过滤。
6.根据权利要求1所述的山药黄精复合饮品制备方法，其特征在于，所述步骤(6)采用灭菌柜(110℃-130℃，1-2磅)灭菌5-10分钟即得。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010278504.5A CN111567708A (zh) | 2020-04-11 | 2020-04-11 | 山药黄精复合饮品制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010278504.5A CN111567708A (zh) | 2020-04-11 | 2020-04-11 | 山药黄精复合饮品制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111567708A true CN111567708A (zh) | 2020-08-25 |
Family
ID=72113018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010278504.5A Pending CN111567708A (zh) | 2020-04-11 | 2020-04-11 | 山药黄精复合饮品制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111567708A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114451506A (zh) * | 2022-02-22 | 2022-05-10 | 韦东 | 一种功能性的复合饮品配方及其生产工艺 |
| CN115581267A (zh) * | 2022-09-27 | 2023-01-10 | 湖南长彤生物科技有限责任公司 | 一种山药黄精复合饮品 |
-
2020
- 2020-04-11 CN CN202010278504.5A patent/CN111567708A/zh active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114451506A (zh) * | 2022-02-22 | 2022-05-10 | 韦东 | 一种功能性的复合饮品配方及其生产工艺 |
| CN115581267A (zh) * | 2022-09-27 | 2023-01-10 | 湖南长彤生物科技有限责任公司 | 一种山药黄精复合饮品 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102106428B (zh) | 一种复方杞枣阿胶养颜茶及其制备方法 | |
| US5807554A (en) | Herbal formulations with nacre | |
| CN101991165B (zh) | 红薯叶-紫苏叶复合饮料及其制备方法 | |
| CN112057551A (zh) | 一种具有滋阴补肾功能的组合物及其制备方法和应用 | |
| CN112409504B (zh) | 一种裸体方格星虫多糖的制备方法和应用 | |
| CN103828954A (zh) | 一种减肥茶及其制作方法 | |
| CN106244371A (zh) | 一种降血糖黄精葡萄保健酒及其生产工艺 | |
| CN102391938B (zh) | 一种玫瑰露酒及其制备方法 | |
| CN111567708A (zh) | 山药黄精复合饮品制备方法 | |
| CN1480055A (zh) | 营养强化健康电脑保健茶及其制备方法 | |
| GB2589967A (en) | Chinese yellow rice wine containing ingredients of mulberry leaves (morus alba L.) and silkworm pupae (bombyx mori) and production method thereof | |
| US6004609A (en) | Ginseng processing method and processed ginseng prepared by the same | |
| CN101828738B (zh) | 防治糖尿病的保健饮料 | |
| CN107744081A (zh) | 一种胡杨碱苏打水 | |
| CN107279443A (zh) | 一种压片糖果及其制备方法 | |
| CN110710678A (zh) | 一种滋补肝肾、养血安神海洋多肽阿胶膏及其制备方法 | |
| CN107557254B (zh) | 一种荔枝玫瑰酒和制备方法及补益气血与抗氧化应用 | |
| CN105029553A (zh) | 一种果汁蛋钙中药保健饮料及其制备方法 | |
| CN107557204B (zh) | 一种混酿荔枝玫瑰酒及其制备方法 | |
| CN101955874B (zh) | 一种苦杏酒的酿造方法 | |
| CN101870940B (zh) | 一种添加牡蛎活性物质的啤酒制备方法 | |
| CN107384680B (zh) | 一种百香果龙眼果酒及其酿造方法 | |
| CN116211999A (zh) | 一种含脾肽增强免疫力的配方及原料制备方法 | |
| CN110093239A (zh) | 一种诺丽配制酒及其制备方法 | |
| CN111528476B (zh) | 一种人参黄精蜜片的配伍组合物及制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200825 |